CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer.
Oncogene. 2021 Oct;40(43):6223-6234. doi: 10.1038/s41388-021-02019-6. Epub 2021 Sep 22.
Oncogene. 2021.
PMID: 34552192